Related Experiment Video
Updated: Nov 15, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Thinking Differently about Cancer Treatment Regimens.
Jeff Settleman1, João M Fernandes Neto2, René Bernards3
1Oncology R&D Group, Pfizer Worldwide Research and Development, San Diego, California.
Most experimental cancer drugs fail in clinical trials, increasing costs. Understanding tumor cell states and signaling pathways can overcome drug resistance, leading to more effective cancer treatments.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Experimental cancer drugs frequently fail in clinical development, raising treatment costs.
- Approved cancer therapies often exhibit limited efficacy in advanced disease due to acquired drug resistance.
- Tumor heterogeneity, characterized by coexisting cell states with distinct vulnerabilities, complicates treatment strategies.
Purpose of the Study:
- To explore promising strategies for overcoming drug resistance in cancer therapy.
- To investigate the role of signaling pathway interactions in mediating drug resistance.
- To leverage the understanding of distinct tumor cell states to develop more effective cancer treatments.
Main Methods:
- Discussion of current challenges in cancer drug development.
- Analysis of mechanisms underlying drug resistance.
- Review of potential therapeutic targets and strategies.
Main Results:
- Identification of signaling pathway crosstalk as a key driver of resistance.
- Recognition of diverse tumor cell vulnerabilities as therapeutic targets.
- Highlighting the potential for innovative treatment regimens.
Conclusions:
- Understanding drug resistance mechanisms is crucial for improving patient outcomes.
- Targeting interactions between signaling pathways and distinct cell states offers a promising avenue for overcoming resistance.
- Developing innovative treatment strategies can lead to more durable clinical benefits for cancer patients.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers